• Elias Ortiz Molina, Rafael Hernandez Pailos, Maria Pola Guillen, Ana Pascual Pedreno, Eduardo Rodriguez Rodriguez, and Antonio Hernandez Martinez.
• Hospital Mancha Centro, Av Constitucion sn, Alcazar de San Juan, Spain, Spain. ortizmolina.e@hotmail.com.
• Ginekol Pol. 2020 Jan 1; 91 (12): 755-763.

ObjectivesDetermine the strengths and weakness of a symptomatic screening for COVID-19 in pregnant women. Analyze the clinical presentation, management, and outcomes.DesignDescriptive retrospective observational study.SettingMancha-Centro Hospital (Spain).Material And MethodsPopulation: Symptomatic pregnant women with confirmed diagnosis of COVID-19. Between the 12th of March and 17th of April 2020, all the symptomatic pregnancies were screened with diagnostic test for SARS-CoV-2. Data collection was done by reviewing the medical records and telephone interviews.Main Outcome MeasuresClinical characteristics, management, treatment, and obstetric and neonatal outcomes.ResultsTwenty patients with positive COVID-19 diagnostic test out of thirty-four suspected. The most common symptoms were fever (70%), cough (65%) and myalgia (35%). A unique symptom of presentation in 20% of cases. COVID-19 pneumonia was diagnosed in 30% by chest X-ray and one case had pulmonary embolism associated diagnosed by CT-Scan. Thromboprophylaxis was indicated in 16 out of 20 patients. Eight women finished their pregnancy during the observation period. Type of birth: 25% natural birth, 12.5% assisted vaginal delivery and 62.5% caesarean section. We had three severe cases, two of them with intensive care support. All neonates had negative test for COVID 19 infection.ConclusionsWe recommend universal screening of all pregnant woman for COVID-19 during the pandemic because of the limits of the symptomatic screening seen in this studio and the ratio of asymptomatic pregnancies with positive test for COVID-19 recently published.

79 keywords...

hide…